日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial

Zasocitinib (TAK-279) 抑制酪氨酸激酶 2 治疗银屑病:一项随机临床试验

Armstrong, April W; Gooderham, Melinda; Lynde, Charles; Maari, Catherine; Forman, Seth; Green, Lawrence; Laquer, Vivian; Zhang, Xinyan; Franchimont, Nathalie; Gangolli, Esha A; Blau, Jessamyn; Zhao, Yiwei; Zhang, Wenwen; Srivastava, Bhaskar; Heap, Graham; Papp, Kim

Canadian Expert Consensus on the Use of Halobetasol Propionate/Tazarotene Lotion for Plaque Psoriasis

加拿大专家对使用丙酸卤倍他索/他扎罗汀乳液治疗斑块状银屑病的共识

Guenther, Lyn; Turchin, Irina; Vender, Ron; Albrecht, Lorne E; Maari, Catherine; Yanofsky, Howard; Prajapati, Vimal H

Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK Inhibitors

口服JAK抑制剂治疗特应性皮炎患者的实验室监测实用建议

Kirchhof, Mark G; Prajapati, Vimal H; Gooderham, Melinda; Hong, Chih-Ho; Lynde, Charles W; Maari, Catherine; Turchin, Irina; Papp, Kim A

Correction to: Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel

更正:对感染艾滋病毒且病情得到控制的患者使用系统疗法治疗银屑病:多学科专家组基于推断的指导意见

Papp, Kim A; Beecker, Jennifer; Cooper, Curtis; Kirchhof, Mark G; Pozniak, Anton L; Rockstroh, Juergen K; Dutz, Jan P; Gooderham, Melinda J; Gniadecki, Robert; Hong, Chih-Ho; Lynde, Charles W; Maari, Catherine; Poulin, Yves; Vender, Ronald B; Walmsley, Sharon L

Ethnicity, Race and Skin Color: Challenges and Opportunities for Atopic Dermatitis Clinical Trials

种族、民族和肤色:特应性皮炎临床试验的挑战与机遇

Bissonnette, Robert; Jankicevic, Jasmina; Saint-Cyr Proulx, Etienne; Maari, Catherine

Palmar syringofibroadenoma-like lesions in Clouston syndrome treated with CO(2) ablative laser

克洛斯顿综合征掌部汗管纤维腺瘤样病变采用二氧化碳消融激光治疗

Safoine, Meryem; Bouffard, Danielle; Netchiporouk, Elena; Maari, Catherine

Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel

系统性疗法在已控制HIV感染者银屑病治疗中的应用:多学科专家组基于推断的指导意见

Papp, Kim A; Beecker, Jennifer; Cooper, Curtis; Kirchhof, Mark G; Pozniak, Anton L; Rockstroh, Juergen K; Dutz, Jan P; Gooderham, Melinda J; Gniadecki, Robert; Hong, Chih-Ho; Lynde, Charles W; Maari, Catherine; Poulin, Yves; Vender, Ronald B; Walmsley, Sharon L

Practical and Relevant Guidelines for the Management of Psoriasis: An Inference-Based Methodology

银屑病管理的实用相关指南:基于推理的方法

Papp, Kim A; Gooderham, Melinda J; Lynde, Charles W; Poulin, Yves; Beecker, Jennifer; Dutz, Jan P; Hong, Chih-Ho; Gniadecki, Robert; Kirchhof, Mark G; Maari, Catherine; Vender, Ronald B

Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials

巴瑞替尼 2 mg 治疗成人特应性皮炎患者的扩展安全性分析:来自八项随机临床试验的综合分析

King, Brett; Maari, Catherine; Lain, Edward; Silverberg, Jonathan I; Issa, Maher; Holzwarth, Katrin; Brinker, Dennis; Cardillo, Tracy; Nunes, Fabio P; Simpson, Eric L

Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond

关于在2019冠状病毒病大流行期间及之后,对炎症性皮肤病患者采取务实免疫疗法的立场声明

Beecker, J; Papp, K A; Dutz, J; Vender, R B; Gniadecki, R; Cooper, C; Gisondi, P; Gooderham, M; Hong, C H; Kirchhof, M G; Lynde, C W; Maari, C; Poulin, Y; Puig, L